Latest Mevion Medical Systems Inc. Stories

LITTLETON, Mass., June 11, 2012 /PRNewswire/ -- Mevion Medical Systems, Inc., a radiation therapy company dedicated to advancing the treatment of cancer, announced today that it has received FDA 510(k) clearance for its MEVION S250 Proton Therapy System. The MEVION S250 is a first-of-its-kind proton therapy system that provides the same precise, non-invasive treatment advantages and capabilities of complex, large, and costly proton therapy systems but with higher patient...

LITTLETON, Mass., March 14, 2012 /PRNewswire/ -- Mevion Medical Systems, a radiation therapy company dedicated to advancing the treatment of cancer, has announced today that it has received CE Marking certification for the MEVION S250 Proton Therapy System. This important commercial milestone indicates that Mevion has completed its development in compliance with the European Union's Medical Device Directive. The CE Marking allows the MEVION S250 to be marketed, sold, and installed in...

LITTLETON, Mass., Jan. 24, 2012 /PRNewswire/ -- Mevion Medical Systems announced today that it has closed a $45 Million investment from ProQuest Investments and its existing investors, including Caxton Heath Life Sciences, Venrock and CHL Medical Partners. Mevion is the manufacturer of the MEVION S250 Proton Therapy System. The capital will be used to accelerate the manufacturing and worldwide deployment of the MEVION S250. Proton beam radiation therapy permits more precise...

LITTLETON, Mass., Oct. 31, 2011 /PRNewswire/ -- Mevion Medical Systems announced today it has delivered the world's first superconducting synchrocyclotron to the S. Lee Kling Center for Proton Therapy at the Siteman Cancer Center at Barnes Jewish Hospital and Washington University School of Medicine in St. Louis MO. This inaugural shipment marks the last phase of the manufacturing of the first MEVION S250 proton accelerator module and the first of many to come deliveries of this...

LITTLETON, Mass., Oct. 3, 2011 /PRNewswire/ -- Mevion Medical Systems, Inc. announced today that it changed its name from Still River Systems, Inc. This change reflects the company's transition from a research and development organization to the commercial manufacturer of the MEVION S250(TM) Proton Therapy System. Proton therapy is widely regarded as the optimal means of delivering therapeutic radiation to treat a variety of cancers, but is not widely available because of the immense size,...